Last reviewed · How we verify
NCT04969406
A Prospective Trial of the Intelon BOSS(TM) System
NA trial testing Brillouin Spectroscopy via BOSS System in Cornea in 23 participants. Terminated before completion.
10 December 2021
Quick facts
| Lead sponsor | Intelon Optics, Inc |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 23 |
| Start date | 24 July 2021 |
| Primary completion | 10 December 2021 |
| Estimated completion | 10 December 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Brillouin Spectroscopy via BOSS System
Conditions studied
- Cornea — all drugs for Cornea →
- Lens Diseases — all drugs for Lens Diseases →
Sponsor
Intelon Optics, Inc
Who can join
18 and older, any sex, with Cornea or Lens Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective, open-label, single-site clinical trial designed to evaluate the repeatability and reproducibility of biomechanical imaging by the BOSS device. Subjects will undergo unilateral biomechanical mapping of the cornea and lens by three BOSS devices operated by three (3) different operators.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04969406
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cornea
Currently open trials in the same condition.
- NCT06483971 — Comparison of Oral Isotretinoin vs Ancomparison of Oral Isotretinoin vs Antibiotics on Corneal Thickness With AV · NA · active not recruiting
- NCT05759780 — OCT Vibrography for Biomechanical Properties of Tissues · NA · recruiting
- NCT03299530 — Accuracy of Corneal Astigmatism in Different Region Modes · recruiting
Other Intelon Optics, Inc trials
Trials by the same sponsor.
- NCT05423041 — A Prospective Clinical Trial Designed to Evaluate the Repeatability and Reproducibility of the Intelon BOSS(tm) System · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04969406 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Intelon Optics, Inc
- Last refreshed: 10 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04969406.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing